(NP (NP Differential/JJ contribution/NN) (PP of/IN (NP herpes/NN simplex/NN virus/NN type/NN 1/CD (NP-COOD (NP gene/NN products/NNS) and/CC (NP cellular/JJ factors/NNS)))) (PP to/TO (NP (NP the/DT activation/NN) (PP of/IN (NP human/JJ immunodeficiency/NN virus/NN type/NN 1/CD provirus/NN)))) ./.)
(S (NP-SBJ We/PRP) (VP have/VBP (ADVP-TMP previously/RB) (VP reported/VBN (SBAR that/IN (S (NP-SBJ (NP infection/NN) (PP with/IN (NP (NP herpes/NN simplex/NN virus/NN type/NN 1/CD) (PRN -LRB-/-LRB- (NP HSV-1/NN) -RRB-/-RRB-)))) (VP activates/VBZ (NP (NP expression/NN) (PP of/IN (NP the/DT (NP (NP human/JJ immunodeficiency/NN virus/NN type/NN 1/CD) (PRN -LRB-/-LRB- (NP HIV-1/NN) -RRB-/-RRB-)) provirus/NN)) (PP in/IN (NP T/NN cells/NNS)))))))) ./.)
(S (NP-SBJ (NP Activation/NN) (PP of/IN (NP the/DT HIV-1/NN provirus/NN))) (VP correlated/VBD (PP with/IN (NP (NP the/DT activation/NN) (PP of/IN (NP-COOD (NP (NP binding/NN) (PP of/IN (NP (ADJP-COOD (ADJP (NP 55-/CD) (NP *?*/-NONE-)) and/CC (ADJP 85-kDa/JJ)) proteins/NNS)) (PP to/TO (NP the/DT kappa/NN B/NN enhancer/NN))) and/CC (NP (NP binding/NN) (PP of/IN (NP the/DT 50-kDa/JJ HLP-1/NN protein/NN)) (PP to/TO (NP (NP the/DT LBP-1/NN sequences/NNS) (PP of/IN (NP the/DT HIV-1/NN long/JJ terminal/JJ repeat/NN)))))))))) ./.)
(S (NP-SBJ (NP Further/RB examination/NN) (PP of/IN (NP this/DT system/NN))) (VP has/VBZ (VP shown/VBN (SBAR that/IN (S (NP-SBJ (NP the/DT inhibition/NN) (PP of/IN (NP HSV-1/NN replication/NN)) (PP by/IN (NP the/DT antiviral/JJ drug/NN acyclovir/NN))) (VP does/VBZ not/RB (VP inhibit/VB (NP (NP HSV-1-mediated/JJ induction/NN) (PP of/IN (NP HIV-1/NN provirus/NN))))))))) ./.)
(S (ADVP Surprisingly/RB) ,/, (NP-SBJ-1 the/DT (NP-COOD (NP NF-kappa/NN B/NN) and/CC (NP HLP-1/NN)) binding/NN activities/NNS) (VP were/VBD (VP (ADVP substantially/RB) inhibited/VBN (NP *-1/-NONE-) (PP in/IN (NP acyclovir-treated/JJ cells/NNS)))) ./.)
(S-COOD (S (PP In/IN (NP the/DT transient-transfection/JJ assay/NN)) ,/, (NP-SBJ-COOD (NP ICP0/NN) ,/, (CONJP but/CC not/RB) (NP ICP4/NN) ,/,) (VP activated/VBD (NP the/DT HIV-1/NN long/JJ terminal/JJ repeat/NN promoter/NN region/NN))) and/CC (S (NP-SBJ-2 (NP the/DT effect/NN) (PP of/IN (NP ICP0/NN))) (VP was/VBD (VP (ADVP greatly/RB) enhanced/VBN (NP *-2/-NONE-) (PP in/IN the/DT presence/NN of/IN (NP the/DT NF-kappa/NN B/NN binding/NN proteins/NNS)) ,/, (S (NP-SBJ */-NONE-) (VP suggesting/VBG (SBAR that/IN (S (NP-SBJ (NP induction/NN) (PP of/IN (NP the/DT HIV-1/NN provirus/NN))) (VP involves/VBZ (NP (NP cooperation/NN) (PP between/IN (NP-COOD (NP (NP the/DT HSV-1-activated/JJ cellular/JJ factor/NN) ,/, (NP NF-kappa/NN B/NN)) ,/, and/CC (NP (NP the/DT virus-encoded/JJ transactivator/NN) ,/, (NP ICP0/NN))))))))))))) ./.)
